Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q4 2021 Earnings Conference Call February 24, 2022 4:30 PM ET Â | --- | |--------------------------------------------------| | | | Company Participants | | Aron Feingold - Head of Corporate Communications | | Sandy Macrae - CEO | | Mark McClung - COO | | Prathyusha Duraibabu - CFO | | Jason Fontenot - Chief Scientific Officer | | Rob Schott - Head of Development | | Bettina Cockroft - Chief Medical Officer | | Conference Call Participants | | Nicole Germino - Truist ...